Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen total Product Sales — Worldwide ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Income & Form 8-K Product Sales Detail
Latest, Q2 2026
9,537
Period ended Jun 30, 2026
Change on a year earlier
+8.7%
8,771 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
28
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Product Sales — Worldwide ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 9,537 | +8.7% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 8,218 | +4.4% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 9,367 | +7.5% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 9,137 | +12.1% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 8,771 | +9.1% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 7,873 | +10.6% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 8,716 | +11.3% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 8,151 | +24.5% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 8,041 | +20.3% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2024 | Mar 31, 2024 | 7,118 | +21.8% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 7,833 | +19.6% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2023 | Sep 30, 2023 | 6,548 | +5.0% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 6,683 | +6.4% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 5,846 | +2.0% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 6,552 | +4.5% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2022 | Sep 30, 2022 | 6,237 | -1.3% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2022 | Jun 30, 2022 | 6,281 | +2.7% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | 5,731 | +2.5% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,271 | -1.0% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2021 | Sep 30, 2021 | 6,320 | +3.5% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | 6,114 | +3.5% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 5,592 | -5.1% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | 6,334 | +7.7% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 6,104 | +11.7% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2020 | Jun 30, 2020 | 5,908 | +6.0% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2020 | Mar 31, 2020 | 5,894 | +11.5% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2019 | Dec 31, 2019 | 5,881 | -2.0% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2019 | Sep 30, 2019 | 5,463 | -0.9% | Form 10-K (filed 2021-02-09) ↗ |
| Q2 2019 | Jun 30, 2019 | 5,574 | -1.8% | Form 10-K (filed 2021-02-09) ↗ |
| Q1 2019 | Mar 31, 2019 | 5,286 | -1.1% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 6,001 | +7.8% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 5,510 | +1.0% | Form 10-Q (filed 2019-10-30) ↗ |
| Q2 2018 | Jun 30, 2018 | 5,679 | +1.9% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2018 | Mar 31, 2018 | 5,343 | +2.8% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2017 | Dec 31, 2017 | 5,569 | -1.7% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 5,453 | -1.1% | Form 10-K (filed 2019-02-13) ↗ |
| Q2 2017 | Jun 30, 2017 | 5,574 | +1.8% | Form 10-K (filed 2019-02-13) ↗ |
| Q1 2017 | Mar 31, 2017 | 5,199 | -0.8% | Form 10-K (filed 2019-02-13) ↗ |
| Q4 2016 | Dec 31, 2016 | 5,663 | +6.3% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2016 | Sep 30, 2016 | 5,516 | 0.0% | Form 10-K (filed 2018-02-13) ↗ |
| Q2 2016 | Jun 30, 2016 | 5,474 | +4.8% | Form 10-K (filed 2018-02-13) ↗ |
| Q1 2016 | Mar 31, 2016 | 5,239 | +7.5% | Form 10-K (filed 2018-02-13) ↗ |
| Q4 2015 | Dec 31, 2015 | 5,329 | – | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2015 | Sep 30, 2015 | 5,516 | – | Form 10-K (filed 2017-02-14) ↗ |
| Q2 2015 | Jun 30, 2015 | 5,225 | – | Form 10-K (filed 2017-02-14) ↗ |
| Q1 2015 | Mar 31, 2015 | 4,874 | – | Form 10-K (filed 2017-02-14) ↗ |
Breakdown
What makes up total product sales — worldwide ($m)
- Total Product Sales — United States ($M)6,990 · Q2 2026
- Total Product Sales — Rest of World (ROW) ($M)2,547 · Q2 2026
- Total Product Sales — Worldwide reported growth YoY (%)9.0% · Q2 2026
- Total Product Sales — Worldwide volume growth YoY (%)9.0% · Q1 2026
- Total Product Sales — Worldwide net selling price change YoY (%)-2.0% · Q1 2026
Cite this data
StockData. (2026). Amgen Total Product Sales — Worldwide ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod_total_ww
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.